The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Checkmate-040: Nivolumab (NIVO) in patients (pts) with advanced hepatocellular carcinoma (aHCC) and Child-Pugh B (CPB) status.
 
Masatoshi Kudo
Honoraria - Abbvie; Bayer; Bristol-Myers Squibb Japan; EA Pharma; Eisai; Gilead Sciences; Merck Serono; Merck Serono; MSD; Novartis; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; MSD
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb Japan (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Otsuka (Inst); Taiho Pharmaceutical (Inst)
 
Ana Matilla
No Relationships to Disclose
 
Armando Santoro
No Relationships to Disclose
 
Ignacio Melero
Consulting or Advisory Role - Alligator Bioscience; Bristol-Myers Squibb; CytomX Therapeutics; EMD Serono; F-Star; Genmab; Roche
Research Funding - Alligator Bioscience; Bristol-Myers Squibb; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Antonio Cubillo Gracian
No Relationships to Disclose
 
Mirelis Acosta-Rivera
Speakers' Bureau - Bristol-Myers Squibb; Merck
 
Su Pin Choo
Honoraria - Bayer; Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Eisai; Novartis; Shire; Sirtex Medical
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Amgen; Bayer; Bristol-Myers Squibb; Merck
 
Anthony B. El-Khoueiry
Honoraria - Bayer; Bristol-Myers Squibb; Eisai; EMD Serono; Merck; Novartis; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; CytomX Therapeutics; Eisai; EMD Serono; Exelixis; Merck; Roche
Research Funding - Astex Pharmaceuticals; AstraZeneca
 
Ryoko Kuromatsu
Honoraria - Daiichi Sankyo; GE Healthcare; Mitsubishi Tanabe Pharma; MSD; Shionogi
Research Funding - AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; EA Pharma; Eisai; MSD K.K; Ono Pharmaceutical; Takeda
 
Bassel F. El-Rayes
Honoraria - Bayer; Lexicon; RTI Health Solutions
Consulting or Advisory Role - Bayer; BTG; Loxo; Merrimack; RTI Health Solutions
Speakers' Bureau - Bristol-Myers Squibb; Lexicon
Research Funding - AVEO (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Cleave Biosciences (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); Hoosier Cancer Research Network (Inst); ICON Clinical Research (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); PPD (Inst); Taiho Pharmaceutical (Inst)
 
Kazushi Numata
No Relationships to Disclose
 
Yoshito Itoh
Honoraria - Abbvie; Ajinomoto; Asahi Kasei; ASKA Pharmaceutical; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Eisai; Fujifilm; Gilead Sciences; GlaxoSmithKline K.K.; Janssen; Kowa; Merck Sharp & Dohme; Mitsubishi Tanabe Pharma; Mylan; Otsuka; Sanofi; Sumitomo Dainippon; Sysmex; Taiho Pharmaceutical; Taisho Toyama Pharma; Takeda; Tsumura & Co.; Zeria Pharmaceutical
Consulting or Advisory Role - Gilead Sciences
Research Funding - Abbvie; Ajinomoto; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Eisai; Fujifilm; Gilead Sciences; GlaxoSmithKline; Kyorin; Merck Serono; Merck Sharp & Dohme; Mitsubishi Tanabe Pharma; Nichinichi Pharmaceutical; Novo Nordisk; Ono Pharmaceutical; Otsuka; Sumitomo Dainippon; Takeda
 
Francesco Di Costanzo
No Relationships to Disclose
 
Oxana V. Crysler
No Relationships to Disclose
 
Maria Reig
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; BTG; Ipsen; Lilly
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Lilly
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Ipsen; Lilly
Research Funding - Bayer
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb
 
Yun Shen
Employment - Bristol-Myers Squibb; Bristol-Myers Squibb (I)
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Jaclyn Neely
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Christine Marie Dela Cruz
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Carlos Baccan
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Bruno Sangro
Consulting or Advisory Role - Adaptimmune; AstraZeneca; Bayer; Bristol-Myers Squibb; BTG; Merck; Onxeo; Sirtex Medical; TERUMO
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Sirtex Medical; TERUMO